WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Pro Bono
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

4.29.26

Firm Advises Match Group on $100 Million Investment in Sniffies
On April 27, 2026, Match Group, a leading provider of digital technologies designed to help people make meaningful connections, announced a $100 million investment in Sniffies, a map-based platform serving non-heterosexual men. The investment represents a significant minority ownership stake and includes the option to acquire the remaining equity in the future. Sniffies will continue to operate independently and remain founder-led, with Match Group supporting the team's vision and growth. Wilson Sonsini Goodrich & Rosati advised Match Group on the transaction.
Client Highlights

10.21.25

Wilson Sonsini Advises Armada Acquisition Corp. II on $1 Billion Business Combination with Evernorth Holdings
On October 20, 2025, Armada Acquisition Corp II (Armada II), a publicly traded special purpose acquisition company, and Evernorth Holdings Inc. (Evernorth), a newly formed Nevada corporation focused on enabling institutional-scale adoption of XRP, announced that they have entered into a definitive business combination agreement through which Evernorth will become a publicly listed company. The transaction is expected to raise more than $1 billion in gross proceeds, establishing Evernorth as the largest public XRP-treasury company and a first-of-its-kind institutional vehicle built to accelerate XRP adoption. Investors include SBI, Ripple, Rippleworks, and leading digital-asset and fintech investors such as Pantera Capital, Kraken, and GSR, with participation from Ripple co-founder Chris Larsen. Upon closing, the combined company will operate under the Evernorth name and is expected to trade on Nasdaq under the ticker symbol “XRPN,” subject to applicable listing requirements and other customary closing conditions.
Client Highlights

9.19.25

Wilson Sonsini Advises Anysphere on Acquisition of Koala
Anysphere, the company behind the artificial intelligence coding application Cursor, acquired Koala, an AI-powered customer relationship management start-up. The acquisition brings Koala’s top engineers to Cursor to help build out a dedicated enterprise-readiness team. Wilson Sonsini Goodrich & Rosati advised Anysphere on the transaction.
Client Highlights

6.06.25

Wilson Sonsini Advises Plus on Business Combination with Churchill IX
On June 5, 2025, Plus Automation (Plus), a physical AI company commercializing AI-based virtual driver software for autonomous trucks, and Churchill Capital Corp IX (Churchill IX), a special purpose acquisition company, announced that they have entered into a definitive agreement to effect a business combination. Wilson Sonsini Goodrich & Rosati advised Plus on the transaction.
Client Highlights

8.09.24

Wilson Sonsini Advises Recursion on Definitive Agreement with Exscientia
On August 8, 2024, Recursion and Exscientia announced the companies have entered into a definitive agreement, combining Recursion, a leading clinical stage technology-enabled biotech company decoding biology to industrialize drug discovery, with Exscientia, a technology-driven clinical stage drug design and development company, committed to creating more effective medicines for patients, faster. Wilson Sonsini Goodrich & Rosati advised Recursion on the transaction.
Client Highlights

6.20.24

Firm Advises Silk Road Medical on $1.26 Billion Acquisition by Boston Scientific
On June 18, 2024, Silk Road Medical announced that it entered into a definitive agreement to be acquired by Boston Scientific Corporation for a purchase price of $27.50 per share, reflecting an aggregate equity value of approximately $1.26 billion. Silk Road Medical is a medical device company that has developed an innovative platform of products to prevent stroke in patients with carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR). Wilson Sonsini Goodrich & Rosati advised Silk Road Medical on the transaction.
Client Highlights

5.02.24

Wilson Sonsini Advises Aledade in Acquisition of Medical Advantage
On May 1, 2024, Aledade, the nation’s largest and most successful network of physician-led value-based care, announced that it has acquired Michigan-based Medical Advantage, which since 2014 has operated as a wholly-owned subsidiary of The Doctors Company, the nation's largest physician-owned medical malpractice insurer. Wilson Sonsini advised Aledade on the transaction.

The partnership bolsters Aledade’s status as the nation’s preeminent primary care Accountable Care Organization (ACO) network and a recognized leader in value-based care. It also expands Michigan physician partnerships with Aledade from 35 to approximately 700. Aledade also will sustain Medical Advantage’s status as a physician organization able to participate in value-based care arrangements with both public and private payers, including Blue Cross Blue Shield of Michigan.

The Wilson Sonsini team that advised Aledade on the transaction includes:

Corporate/M&A
Steve Bernard
Mike Russell
Andrew Lombardo
Ava Munson
Zachary Williams
Cindy West
Client Highlights

7.17.23

Wilson Sonsini Advises DTx Pharma on Acquisition by Novartis
On July 17, 2023, DTx Pharma, a preclinical-stage biotechnology company addressing the delivery challenges of oligonucleotide therapeutics with its Fatty Acid Ligand Conjugated OligoNucleotide (FALCON™) platform, announced that it has been acquired by Novartis. Wilson Sonsini Goodrich & Rosati advised DTx Pharma on the transaction.
Client Highlights

7.14.23

Wilson Sonsini Advises Entrata on Acquisition of Rent Dynamics
On July 13, 2023, Entrata, a leading operating system for multifamily communities, announced its acquisition of Rent Dynamics, a provider for resident rent reporting and financial resources. Entrata has acquired 100 percent of the equity in Rent Dynamics and will be able to provide residents with increased access to financial tools designed to positively impact their financial future. Wilson Sonsini Goodrich & Rosati advised Entrata on the transaction.
Client Highlights

8.16.22

Wilson Sonsini Advises Lumentum on Acquisition of IPG Photonics’ Telecom Transmission Product Lines
On August 15, 2022, Lumentum Holdings Inc. announced that it has acquired IPG Photonics' telecom transmission product lines in an all-cash transaction. According to the press release, the acquisition adds "highly complementary and differentiated transceiver product lines and ASIC capabilities" to Lumentum, which will "help expand [the] addressable market and augment [Lumentum's] technology capabilities.” Terms of the transaction were not disclosed.
Client Highlights

3.28.22

Wilson Sonsini Represents Poly in $3.3 Billion Acquisition by HP Inc.
On March 28, 2022, HP Inc. announced a definitive agreement to acquire Poly, a leading global provider of workplace collaboration solutions, in an all-cash transaction for $40 per share, implying a total enterprise value of $3.3 billion, inclusive of Poly’s net debt. Wilson Sonsini Goodrich & Rosati is representing Poly in the transaction.

The acquisition accelerates HP’s strategy to create a more growth-oriented portfolio, further strengthens its industry opportunity in hybrid work solutions, and positions the company for long-term, sustainable growth and value creation. Poly will help drive the growth and scale of HP’s peripherals and workforce solutions businesses. Poly’s devices, software, and services, combined with HP’s strengths across compute, device management, and security, create a robust portfolio of hybrid meeting solutions. Poly is a leader in video conferencing solutions, cameras, headsets, voice, and software. Together, HP and Poly will deliver a complete ecosystem of devices, software, and digital services to create premium employee experiences, improve workforce productivity, and provide enterprise customers with better visibility, insights, security, and manageability across their hybrid IT environments.
Client Highlights

12.22.21

Wilson Sonsini Advises Encora on Its Acquisition by Advent International
On December 21, 2021, Encora, a global digital engineering services company specializing in software product development services for fast-growing enterprises and digitally native companies, and Advent International, a leading global private equity firm, announced that Advent has acquired a majority stake in Encora's business. As part of the agreement, Warburg Pincus, the existing majority shareholder of Encora, retains a minority stake. Wilson Sonsini Goodrich & Rosati represented Encora in the transaction.
  • 1
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.